Stability of valganciclovir in an extemporaneously compounded oral liquid.
Anaizi NH, Dentinger PJ, Swenson CF Am J Health Syst Pharm 2002;59:1267-- 1270.
The procedure for compounding an oral suspension of valganciclovir 90 mg/mL from tablets in a cherry-chocolate syrup vehicle is described. The authors' stability testing indicates that this oral suspension retains more than 90% of the initial valganciclovir concentration when stored in amber polyethylene terephthalate bottles in a refrigerator at 2 deg C to 8 deg C for 125 days.
Copyright International Journal of Pharmaceutical Compounding Mar/Apr 2003
Provided by ProQuest Information and Learning Company. All rights Reserved